1. Home
  2. IPSC vs PMEC Comparison

IPSC vs PMEC Comparison

Compare IPSC & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • PMEC
  • Stock Information
  • Founded
  • IPSC 2019
  • PMEC 1984
  • Country
  • IPSC United States
  • PMEC Singapore
  • Employees
  • IPSC N/A
  • PMEC N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • PMEC
  • Sector
  • IPSC Health Care
  • PMEC
  • Exchange
  • IPSC Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • IPSC 45.4M
  • PMEC 38.4M
  • IPO Year
  • IPSC 2021
  • PMEC 2023
  • Fundamental
  • Price
  • IPSC $0.55
  • PMEC $1.02
  • Analyst Decision
  • IPSC Strong Buy
  • PMEC
  • Analyst Count
  • IPSC 6
  • PMEC 0
  • Target Price
  • IPSC $3.00
  • PMEC N/A
  • AVG Volume (30 Days)
  • IPSC 1.5M
  • PMEC 197.8K
  • Earning Date
  • IPSC 11-13-2025
  • PMEC 01-01-0001
  • Dividend Yield
  • IPSC N/A
  • PMEC N/A
  • EPS Growth
  • IPSC N/A
  • PMEC N/A
  • EPS
  • IPSC N/A
  • PMEC N/A
  • Revenue
  • IPSC $113,337,000.00
  • PMEC $74,349,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • PMEC N/A
  • Revenue Next Year
  • IPSC N/A
  • PMEC N/A
  • P/E Ratio
  • IPSC N/A
  • PMEC N/A
  • Revenue Growth
  • IPSC 4122.69
  • PMEC 2.52
  • 52 Week Low
  • IPSC $0.34
  • PMEC $0.54
  • 52 Week High
  • IPSC $1.83
  • PMEC $2.44
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 52.98
  • PMEC 37.16
  • Support Level
  • IPSC $0.46
  • PMEC $0.98
  • Resistance Level
  • IPSC $0.56
  • PMEC $1.04
  • Average True Range (ATR)
  • IPSC 0.04
  • PMEC 0.14
  • MACD
  • IPSC 0.00
  • PMEC 0.02
  • Stochastic Oscillator
  • IPSC 76.21
  • PMEC 40.84

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: